The effect of the uremic toxin cyanate (CNO-) on anaerobic cysteine metabolism and oxidative processes in the rat liver: A protective effect of lipoate

Toxicology Mechanisms and Methods

Volumn 21, Issue 6, 2011, Pages 473-478

  Sokołowska, Maria ^a   Niedzielska, Ewa ^a   Iciek, Małgorzata ^a   Bilska, Anna ^a   Lorenc Koci, Elzbieta ^b   Włodek, Lidia ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Cyanate; lipoic acid; sulfane sulfur

Indexed keywords

3 MERCAPTOPYRUVIC ACID; CYANIC ACID; CYSTATHIONINE GAMMA LYASE; CYSTEINE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SULFOTRANSFERASE; THIOCTIC ACID; THIOL GROUP; THIOSULFATE SULFURTRANSFERASE; UREMIC TOXIN;

AMINO ACID METABOLISM; ANAEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

ANIMALS; ANTIOXIDANTS; CYANATES; CYSTEINE; HYDROGEN SULFIDE; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; LIVER; MALE; MOLECULAR TARGETED THERAPY; OXIDANTS; OXIDATIVE STRESS; POISONS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS; THIOCTIC ACID; THIOSULFATE SULFURTRANSFERASE; UREMIA;

RATTUS;

EID: 79958226943     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2011.556155     Document Type: Article

References (36)

1. Antecka E, Włodek P, Iciek M, Miłkowski A, Smoleński O. 2005. Changes of reduced thiols levels and sulfurtransferases activity in erythrocytes of patients with terminal renal failure. Nephrol Dial Pol 9:179-183.
2. Arlandson M, Deckert T, Roongta VA, Bonilla L, Mayo KH, MacPherson JC, et al. (2001). Eosinophil peroxidase oxidation of thiocynate. J Biol Chem 276:215-224.
3. Bilska A, Dudek M, Iciek M, Kwiecien I, Sokolowska-Jezewicz M, Filipek B, Wlodek L. 2008. Biological actions of lipoic acid associated with sulfane sulfur metabolism. Pharmacol Rep 60:225-232.
4. Bilska A, Kryczyk A, Wlodek L. 2007. The different aspects of the biological role of glutathione. Postepy Hig Med Dosw 61:438-453.
5. Bilska A, Wlodek L. 2002. [Biologic properties of lipoic acid]. Postepy Hig Med Dosw 56:201-219.
6. Bilska A, Wlodek L. 2005. Lipoic acid - the drug of the future? Pharmacol Rep 57:570-577.
7. Bondy SC, Guo SX. 1994. Effect of ethanol treatment of indices of cumulative oxidative stress. Eur J Pharmacol 270:349-355.
8. Bustamante J, Lodge JK, Marcocci L, Tritchler HJ, Packer L, Rihm BH. 1998. α-Lipoic acid in liver metabolism and disease. Free Radic Biol Med 24:1023-1039. (Pubitemid 28186244)
9. Cianci M, Gliubich F, Zanotti G, Berni R. 2000. Specific interaction of lipoate at the active site of rhodanese. Biochim Biophys Acta 1481:103-108. (Pubitemid 30658086)
10. Cipollone R, Ascenzi P, Frangipani E, Visca P. 2006. Cyanide detoxification by recombinant bacterial rhodanese. Chemosphere 63:942-949.
11. Estiu G, Merz KM Jr. 2007. Competitive hydrolytic and elimination mechanisms in the urease catalyzed decomposition of urea. J Phys Chem B 111:10263-10274. (Pubitemid 47388033)
12. Hall AH, Rumack BH. 1986. Clinical toxicology of cyanide. Ann Emerg Med 15:1067-1074. (Pubitemid 16017766)
13. Hasuike Y, Nakanishi T, Moriguchi R, Otaki Y, Nanami M, Hama Y, Naka M, Miyagawa K, Izumi M, Takamitsu Y. 2004. Accumulation of cyanide and thiocyanate in haemodialysis patients. Nephrol Dial Transplant 19:1474-1479. (Pubitemid 38786741)
14. Iciek M, Wlodek L. 2001. Biosynthesis and biological properties of compounds containing highly reactive, reduced sulfane sulfur. Pol J Pharmacol 53:215-225.
15. Klin M, Smogorzewski M, Massry SG. 1995. Chronic renal failure increases cytosolic ([Ca2+]i) of hepatpcytes. Am J Physol 169:103-109.
16. Kossahum K. 1994. Effects on carbamate thioester of methyl and 2- chloroethyl isocyanate on glutatione levels and gluthatione reductase activity in isolated rat hepatocytes. Biochem Pharmacol 48:587-594.
17. Koyama K, Yoshida A, Takeda A, Morozumi K, Fujinami T, Tanaka N. 1997. Abnormal cyanide metabolism in uraemic patients. Nephrol Dial Transplant 12:1622-1628. (Pubitemid 27346287)
18. Kraus LM, Kraus AP. 2001. Carbamylation of amino acids and proteins in uremia, Kidney Int 59(Suppl 78):102-107.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
20. Nagahara N., Nishino T. 1996. Role of Amino Acid Residues in the Active Site of Rat Liver Mercaptopyruvate Sulfurtransferase. J Biol Chem 271:27395-27401.
21. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358. (Pubitemid 9194347)
22. Saidu Y. 2004. Physicochemical features of rhodanese: A review. Afr J Biotechnol 3:370-374. (Pubitemid 40706060)
23. Sedlak J, Lindsay RH. 1968. Estimation of Total Protein-Bound and Nonprotein Sulfhydryl Groups in Tisue with Ellmans Reagent. Anal Biochem 25:192-205.
24. Smogorzewski MJ, Massry SG. 2003. Liver metabolism in CRF. Am J Kidney Dis 41:S127-S132. (Pubitemid 36278362)
25. Soda K. 1967. A spectrofotometric microdetermination of keto acids with 3-methyl-2-benzothiazolone hydrazone. Agric Biol Chem 31:1054-1060.
26. Sörbo BH. 1955. Rhodanese. Methods in Enzymology, vol. II, Academic Press, New York, pp. 334-337.
27. Stark GR, Stein WH, Moor S. 1960. Reactions of the cyanate present in aqueous urea with amino acids and proteins. J Biol Chem 235:3177-3188.
28. Sumathi R, Baskaran G, Varalakshmi P. 1996. Effect of DL-lipoic acid on tissue redox state in acute cadmium-challenged tissues. J Nutr Biochem 7:85-92.
29. Tor-Agbidye J, Palmer VS, Spencer PS, Craig Am, Blythe LL, Sabri MI. 1999. Sodium cyanate alters gluthatione homeostasis in rodent brain: relationship to neurodegenerative diseases in protein-deficient malnourished populations in Afrika. Brain Res 820:12-19. (Pubitemid 29225474)
30. Valentine WN, Frankenfeld I. 1974. 3-Mercaptopyruvate sulfurtransferase (E.C.2.8.1.2.): a simple assay adapted to human blood cells. Clin Chim Acts 51:205-210.
31. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group (EUTox). 2003. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934-1943. (Pubitemid 36513344)
32. Vanholder R, Schepers E, Meert N, Lameire N. 2006. What is uremia? Retention versus oxidation. Blood Purif 24:33-38. (Pubitemid 41820819)
33. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL. 2007. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13:1176-1184. (Pubitemid 47530630)
34. Winiarska K, Malinska D, Szymanski K, Dudziak M, Bryla J. 2008. Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits. Biochimie 90:450-459.
35. Wisnewski A, Lemus R, Karol MH, Redlich CA. 1999. Isocyanate? conjugated human lung epithelial cell proteins: A link between exposure and asthma? J Allergy Clin Immunol 343:341-347. (Pubitemid 29420431)
36. Wood JL. 1987. Sulfane sulfur. Meth Enzymol 143:25-29.